James R. Spivey, MD
James Spivey, MD, associate professor of Medicine, Division of Digestive Diseases and The Emory Transplant Center and medical director, Liver Transplantation and Clinical Director, Hepatology, started practicing at Emory in 2005.
Specialties
- Internal Medicine (Board certified since 1983)
- Gastroenterology (Board certified since 1993, recertified 2003)
- Hepatology (Certificate of Added Qualification in Transplant Hepatology, 2006)
Areas of Expertise
- Hepatitis
- Liver cancer
- Chronic liver disease
- Liver transplantation
Groundbreaking Research and Clinical Trials
Dr. Spivey is currently participating in a multicenter, randomized trial to treat Hepatitis B patients after liver transplantation with Truvada® in an effort to discontinue Hepatitis B Immune Globulin.
The Road to Emory: Education
- Medical School: Tulane Medical School, New Orleans, LA 1980
- Internship: North Carolina Baptist Hospital, Winston-Salem, NC 1983
- Fellowship: University of Miami, Miami, FL, 1990 (Hepatology); Mayo Clinic, Rochester, MN, 1992 (Gastroenterology)
Memberships
- American Association for the Study of Liver Diseases
- American Gastroenterological Association
- American Society of Transplantation
Major or Current Publications
- Schmitt TM, Hughes CB, Bonatti H, Harnois DM, Nguyen JH, Dickson RC, Spivey JR, Steers JL. Gallbladder cancer and liver transplantation. Transpl Int. 2005;18(1)52-5.
- Hellinger WC, Bonatti H, Yao JD, Alvarez S, Brumble LM, Keating MR, Mendez JC, Kramer DJ, Dickson RC, Harnois DM, Spivey JR, Hughes CB, Nguyen JH, Steers JL. Risk stratification and targeted antifungal prophylaxis for prevention of aspergillosis and other invasive mold infections after liver transplantation. Liver Transpl. 2005;11(6):656-62.
- Hellinger, Walter C, Bonatti, Hugo, Machicao, Victor I., Yao, Joseph D., Brumble, Lisa M., Alvarez, Salvador, Weigand, Stephen D., Dickson, Rolland C., Harnois, Denise M., Spivey, James R., Stapelfeldt, Wolf H., Hughes, Christopher B., Nguyen, Justin H., Steers, Jeffery L.; Effect of Antiviral Chemoprophylaxis on Adverse Clinical Outcomes Associated With Cytomegalovirus After Liver Transplantation. Mayo Clin Proc. Volume 81, #8, 2006:1023-1028.
- Lauenstein, Thomas C., Salman, Khalil, Morreira, Roger, Heffron, Thomas, Spivey, James R., Martinez, Enrique, Sharma, Puneet, and Martin, Diego R. Gadolinium-Enhanced MRI for Tumor Surveillance Before Liver Transplantation: Center-Based Experience Am. J. Roentgenol., Sep 2007; 189: 663 - 670.
- Changing Management and Outcome; Hepatocellular Carcinoma; Evaluation of 501 Patients Treated at a Single Comprehensive Center. Kooby DA, Egnatashvilli V, Graiser M, Delman KA, Spivey J, Wood WC and Staley CA. Submitted.
Personal
Dr. Spivey and his wife of 33 years, Katie Spivey, have two sons, Rick and Joseph. Dr. Spivey will soon qualify for his private pilot's license.
